Team:Rice University/STRATEGY
From 2008.igem.org
(Difference between revisions)
StevensonT (Talk | contribs) (→Circuit Design for Recombination in Yeast) |
StevensonT (Talk | contribs) (→Circuit Design for Recombination in Yeast) |
||
Line 41: | Line 41: | ||
*#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122001 pGAL1 TetO ZeoR] - provides galactose inducible, TetR repressible, Zeocin/Bleocin resistance. This part will allow us to select for recombinants. | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122001 pGAL1 TetO ZeoR] - provides galactose inducible, TetR repressible, Zeocin/Bleocin resistance. This part will allow us to select for recombinants. | ||
*#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122004 tADH1] - bi-directional transcriptional stop. Strategically placed downstream of Zeor and upstream of pADH1 to prevent erroneous recombination at those regions. | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122004 tADH1] - bi-directional transcriptional stop. Strategically placed downstream of Zeor and upstream of pADH1 to prevent erroneous recombination at those regions. | ||
- | *Cassette 3 - | + | *Cassette 3 - constitutive expression of TAL |
+ | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122004 pADH1] - constitutive promoter. placed strategically to prevent erroneous recombination with tADH1. | ||
+ | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122005 TAL] - converts L-tyrosine to ''p''-coumaric acid and L-phenylalanine to ''trans''-cinnamic acid. | ||
+ | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122013 tPGK1] - dual purpose of 3' homologous recombination region and bi-directional transcriptional terminator. | ||
Revision as of 00:23, 30 October 2008
OUR TEAM ::: SUMMARY ::: INTRODUCTION ::: STRATEGY ::: RESULTS ::: ONGOING WORK
OUR TEAM ::: SUMMARY ::: INTRODUCTION ::: STRATEGY ::: RESULTS ::: ONGOING WORK |